2、新药上市申请受理药品名称企业名称分类受理号草酸艾司西酞普兰片Maxmind Pharmaceutical S.L.5.2JYHS2400060草酸艾司西酞普兰片Maxmind Pharmaceutical S.L.5.2JYHS2400059静注人免疫球蛋白(pH4)广东丹霞生物制药有限公司3.4CXSS2400136静注人免疫球蛋白(pH4)广东丹霞生物制药有限公司3.4CXSS2400135利拉鲁肽注射液...
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) in Shanghai andactive pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou,have successfully passed two inspections from theU.S. Food and D...
STA Pharmaceutical Co., Ltd., a WuXi AppTec Company (WuXi STA)–and BioNova Pharmaceuticals (Shanghai) Ltd. ("BioNova") recently announced the signing of a collaboration agreement to jointly accelerate the development and manufacture processes for BioNova's innovative oncology medicines. Ye Hua,...
WuXi STA Forms Strategic Partnership with Ascentage Pharma SHANGHAI, CHINA, June, 3, 2021 –STA Pharmaceutical Co., Ltd., (“WuXi STA”), a leading Contract Development and Manufacturing Organization – and Ascentage Pharma (6855.HK), announced the signing of a strategic partnership agreement. ...
Shanghai, January 3, 2020: STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – today announced the opening of its large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in Changzhou, China. This significant milestone marks WuXi STA’s est...
-ENDS- Notes to editors About WuXi STA STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with operations inChinaandthe United States....
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry, with operations inChinaandthe United States. As a premier Contract Development and Manufacturing...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life sciences industry, with operations inChinaandthe United States. As a premier Contract Development and Manufa...
Shanghai, July 31, 2017: STA Pharmaceutical Co., Ltd. (STA) – a WuXi AppTec company and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing – announces that it has merged with WuXi
STA Pharmaceutical (STA), a subsidiary of WuXi AppTec, opened its new large-scale oligonucleotide API manufacturing facility in Changzhou, in January 2020.